Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 23 Jun 2023

Characterization and outcome of post-transplant lymphoproliferative disorders within a collaborative study

in Hematologic Malignancies

Philipp Lückemeier
Aleksandar Radujkovic
Udo Holtick
Lars Kurch
Astrid Monecke
Uwe Platzbecker
Marco Herling
Sabine Kayser

Frontiers in Oncology

doi 10.3389/fonc.2023.1208028

2,717 views
3 citations

Brief Research Report

Published on 22 Jun 2023

Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies

in Hematologic Malignancies

Francesco Angotzi
Marco Petrella
Tamara Berno
Gianni Binotto
Giorgia Bonetto
Antonio Branca
Marco Carraro
Chiara Adele Cavaretta
Alessandro Cellini
Fabio D’Amore

Frontiers in Oncology

doi 10.3389/fonc.2023.1212752

2,641 views
9 citations

Editorial

Published on 19 Jun 2023

Editorial: Deciphering the bone marrow microenvironment in hematologic malignancies

in Hematologic Malignancies

Manja Wobus
Martin Bornhäuser

Frontiers in Oncology

doi 10.3389/fonc.2023.1231467

1,203 views
1 citation

Editorial

Published on 16 Jun 2023

Editorial: T-cell directed therapies in multiple myeloma

in Hematologic Malignancies

Joshua Richter
Larry D. Anderson
Karthik Ramasamy
Adriana Rossi

Frontiers in Oncology

doi 10.3389/fonc.2023.1206475

1,544 views
3 citations

Original Research

Published on 16 Jun 2023

Therapy of childhood acute lymphoblastic leukemia in resource-poor geospaces

in Hematologic Malignancies

Moisés M. Gallardo-Pérez
Robert Peter Gale
Oscar A. Reyes-Cisneros
Daniela Sánchez-Bonilla
José A. Fernández-Gutiérrez
Wendy Stock
Iván Murrieta-Álvarez
Juan Carlos Olivares-Gazca
Guillermo J. Ruiz-Delgado
Rafael Fonseca

Frontiers in Oncology

doi 10.3389/fonc.2023.1187268

1,964 views
2 citations

Case Report

Published on 15 Jun 2023

Case Report: Severe cutaneous adverse event associated with checkpoint inhibition in the setting of CAR T-cell therapy: beyond CRS

in Hematologic Malignancies

Chiara Masucci
Sara Pepe
Ursula La Rocca
Veronica Zullino
Maria Stefania De Propris
Walter Barberi
Anna Paola Iori
Sabina Martelli
Franco Ruberto
Maurizio Martelli

Frontiers in Oncology

doi 10.3389/fonc.2023.1171031

2,572 views
3 citations

Original Research

Published on 13 Jun 2023

Clonal evolution in tyrosine kinase inhibitor-resistance: lessons from in vitro-models

in Hematologic Malignancies

Meike Kaehler
Pia Osteresch
Axel Künstner
Stella Juliane Vieth
Daniela Esser
Marius Möller
Hauke Busch
Inga Vater
Malte Spielmann
Ingolf Cascorbi

Frontiers in Oncology

doi 10.3389/fonc.2023.1200897

2,969 views
6 citations

Original Research

Published on 13 Jun 2023

Metabolic bulk volume predicts survival in a homogeneous cohort of stage II/III diffuse large B-cell lymphoma patients undergoing R-CHOP treatment

in Hematologic Malignancies

Hyun Jin
Myung Jin
Chae Hong Lim
Joon Young Choi
Seok-Jin Kim
Kyung-Han Lee

Frontiers in Oncology

doi 10.3389/fonc.2023.1186311

2,002 views
3 citations

Systematic Review

Published on 13 Jun 2023

Efficacy and safety of histone deacetylase inhibitors in peripheral T-cell lymphoma: a systematic review and meta-analysis on prospective clinical trials

in Hematologic Malignancies

Peipei Yang
Yali Tao
Ailin Zhao
Kai Shen
He Li
Jinjin Wang
Hui Zhou
Zhongwang Wang
Mengyao Wang
Ying Qu

Frontiers in Oncology

doi 10.3389/fonc.2023.1127112

3,525 views
3 citations

Review

Published on 12 Jun 2023

Transcription factor genetics and biology in predisposition to bone marrow failure and hematological malignancy

in Hematologic Malignancies

Jiarna R. Zerella
Claire C. Homan
Peer Arts
Anna L. Brown
Hamish S. Scott
Christopher N. Hahn

Frontiers in Oncology

doi 10.3389/fonc.2023.1183318

4,134 views
4 citations

Original Research

Published on 09 Jun 2023

Dyslipidemia in diffuse large B-cell lymphoma based on the genetic subtypes: a single-center study of 259 Chinese patients

in Hematologic Malignancies

Yi Xu
Huafei Shen
Yuanfei Shi
Yanchun Zhao
Xiaolong Zhen
Jianai Sun
Xueying Li
De Zhou
Chunmei Yang
Jinhan Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1172623

2,309 views
2 citations

Review

Published on 09 Jun 2023

Myeloproliferative neoplasms – blurring the lines between cancer and chronic inflammatory disorder

in Hematologic Malignancies

Eli M. Soyfer
Angela G. Fleischman

Frontiers in Oncology

doi 10.3389/fonc.2023.1208089

9,047 views
4 citations

Editorial

Published on 09 Jun 2023

Editorial: Real-world data and real-world evidence in hematologic malignancies

in Hematologic Malignancies

Michele Malagola
Robert Ohgami
Raffaella Greco

Frontiers in Oncology

doi 10.3389/fonc.2023.1232980

1,586 views

Case Report

Published on 08 Jun 2023

Case Report: Effects of multiple myeloma therapy on essential thrombocythemia and vice versa: a case of synchronous dual hematological malignancy

in Hematologic Malignancies

Nupur Krishnan
Russell Price
Rouslan Kotchetkov

Frontiers in Oncology

doi 10.3389/fonc.2023.1213942

2,597 views
2 citations

Original Research

Published on 08 Jun 2023

Development and validation of platelet-to-albumin ratio as a clinical predictor for diffuse large B-cell lymphoma

in Hematologic Malignancies

Jinghan Wang
Linjie Li
Fang Yu
Junyu Zhang
Liping Mao
Bocheng Chen
Xuelian Hu
Hongmei Zhou
Wanzhuo Xie
Hongyan Tong

Frontiers in Oncology

doi 10.3389/fonc.2023.1138284

2,382 views
4 citations

Original Research

Published on 08 Jun 2023

Immune cell proportions correlate with clinicogenomic features and ex vivo drug responses in acute myeloid leukemia

in Hematologic Malignancies

Kyle A. Romine
Daniel Bottomly
William Yashar
Nicola Long
Matthew Viehdorfer
Shannon K. McWeeney
Jeffrey W. Tyner

Frontiers in Oncology

doi 10.3389/fonc.2023.1192829

1,919 views
1 citation